Pluristem Therapeutics Inc (PSTI)

[skitahoe]

$60, with only 15 million shares outstanding, amounts to a $.9 billion market cap. It's really not that high if something really big were to occur. I cannot say it will happen, but it's really not beyond the realms of possibilities.

I don't know if FDA approvals are possible next year, or in 2021, but I believe that by 2022 at least one, and possibly two drug approvals are likely. Then the question becomes, how much in earnings could these drugs generate. I believe both have blockbuster potential probably many times over. Certainly by that time we'll no longer have only 15 million shares outstanding, it's also very possible we'll have partners, or possibly have been bought out. If we're not bought out, by that time it's very possible that our market cap reaches double digit billions. Let's say it's $10 billion, and lets say our O.S. is over 3 times what it is today, 50 million shares. That's a $200 a share price.

I don't believe this is overly optimistic, not with approval of both advanced products, and new applications being seen all the time. If in fact many new applications are found where our products help, a $10 billion market cap is probably very low. Earnings won't come instantaneously, but they'll build tremendously year over year.

Gary